Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
almotriptan 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
acebutolol 200 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Carvedilol 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Captopril 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
co-careldopa 12,5 mg + 50 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
amitriptylinhydrochlorid 12,5 mg + chlordiazepoxid 5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
amitriptylin 12,5 mg + chlordiazepoxid 10 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Milnacipran hydrochloride 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
quinalapril 10 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Rofecoxib 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Ketoprofen 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Meclozine hydrochloride 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and telmisartan 40 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Tetrabenazine 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg oral capsule |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
enalaprilmaleat 5 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
hydrochlorthiazid 12,5 mg + quinaprilhydrochlorid 20 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Clozapine 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
clozapin oralt opløselig 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
enalaprilmaleat 20 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
enalaprilmaleat 5 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
hydrochlorthiazid 12,5 mg + quinaprilhydrochlorid 20 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
amitriptylinhydrochlorid 12,5 mg + chlordiazepoxid 5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
3 |
eprosartan 600 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Codeine phosphate 12.5 mg and ibuprofen 200 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
co-careldopa 12,5 mg + 50 mg tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Diclofenac sodium 12.5 mg rectal suppository |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 250 milligram/20 milliliter conventional release solution for infusion vial |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely fluphenazine decanoate 12.5 milligram/0.5 milliliter conventional release solution for injection ampule |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely fondaparinux sodium 5 milligram/0.4 milliliter conventional release solution for injection syringe |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely clomipramine hydrochloride 25 milligram/2 milliliter conventional release solution for injection ampule |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely fondaparinux sodium 7.5 milligram/0.6 milliliter conventional release solution for injection syringe |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely prochlorperazine mesilate 12.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely prochlorperazine mesilate 12.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely clomipramine hydrochloride 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely prochlorperazine mesilate 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely fondaparinux sodium 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Almotriptan (as almotriptan malate) 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |
Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Enalapril maleate 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
3 |
Hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
2 |
Diphenhydramine hydrochloride 12.5 mg chewable tablet |
Has presentation strength numerator value |
False |
12.5 |
Inferred relationship |
Some |
1 |